Report copyright - Developing breakthrough therapies in NASH and ...2).… · Non-confidential –Property of Inventiva │ 6 Key financials and shareholder base ISIN code FR0013233012 Market Euronext
Please pass captcha verification before submit form
Please pass captcha verification before submit form